Trends in intravenous antimicrobial start rates in outpatient hemodialysis centers, United States, 2012-2021

W Wyatt Wilson; Hannah Hua; Qunna Li; Minn M Soe; Ibironke W Apata; Lu Meng; Jeneita M Bell; Emily McDonald; Jonathan R Edwards; Sarah Kabbani; Shannon Novosad

doi:10.1017/ash.2025.37

Trends in intravenous antimicrobial start rates in outpatient hemodialysis centers, United States, 2012-2021

Antimicrob Steward Healthc Epidemiol. 2025 Mar 26;5(1):e87. doi: 10.1017/ash.2025.37. eCollection 2025.

Authors

W Wyatt Wilson^{1

2}, Hannah Hua¹, Qunna Li¹, Minn M Soe¹, Ibironke W Apata^{1

3}, Lu Meng¹, Jeneita M Bell¹, Emily McDonald¹, Jonathan R Edwards¹, Sarah Kabbani¹, Shannon Novosad¹

Affiliations

¹ Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
² Division of Hospital Medicine, Emory School of Medicine, Atlanta, GA, USA.
³ Division of Renal Medicine, Emory School of Medicine, Atlanta, GA, USA.

Abstract

Using National Healthcare Safety Network data, an interrupted time series of intravenous antimicrobial starts (IVAS) among hemodialysis patients was performed. Annual adjusted rates decreased by 6.64% (January 2012-March 2020) and then further decreased by 8.91% until December 2021. IVAS incidence trends have decreased since 2012, including during the early COVID-19 pandemic.